Valuation: Stereotaxis Inc

Market Cap 12Cr 11Cr 9.99Cr 9.1Cr 17Cr 1.16TCr 17Cr 120.83Cr 47Cr 589.6Cr 45Cr 44Cr 1.89TCr P/E 2026 *
-5.9x
P/E 2027 * -8.18x
Enterprise Value 12Cr 11Cr 9.99Cr 9.1Cr 17Cr 1.16TCr 17Cr 120.83Cr 47Cr 589.6Cr 45Cr 44Cr 1.89TCr EV / Sales 2026 *
3.5x
EV / Sales 2027 * 2.63x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 12Cr
-3.34%-3.81%+22.95%+28.91% 24TCr
-4.42%-5.37%-0.53%-14.65% 15TCr
-1.33%+0.43%-8.40%+37.27% 14TCr
-0.96%-3.25%-54.90%-18.12% 6.27TCr
-1.31%-0.63%+11.64%+22.96% 4.91TCr
+1.16%+0.48%-19.06%-21.01% 4.71TCr
-3.27%-3.56%+20.28%+49.06% 4.7TCr
-1.23%+2.58%-3.86%+38.57% 4.56TCr
-3.15%-1.11%+33.06%+55.18% 4.18TCr
Average -2.15%+0.29%+0.13%+19.80% 9.17TCr
Weighted average by Cap. -2.02%+0.45%+3.22%+18.73%

Financials

2026 *2027 *
Net sales 3.43Cr 3.05Cr 2.85Cr 2.6Cr 4.89Cr 330.56Cr 4.96Cr 34Cr 13Cr 168.35Cr 13Cr 13Cr 540.73Cr 4.57Cr 4.06Cr 3.79Cr 3.46Cr 6.51Cr 439.68Cr 6.6Cr 46Cr 18Cr 223.92Cr 17Cr 17Cr 719.22Cr
Net income -2.01Cr -1.79Cr -1.67Cr -1.52Cr -2.87Cr -193.84Cr -2.91Cr -20Cr -7.83Cr -99Cr -7.56Cr -7.4Cr -317.09Cr -1.48Cr -1.31Cr -1.23Cr -1.12Cr -2.1Cr -142.17Cr -2.13Cr -15Cr -5.74Cr -72Cr -5.54Cr -5.42Cr -232.57Cr
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-